Skip to main content
Premium Trial:

Request an Annual Quote

Protedyne Completes $10M Series D Financing Round

NEW YORK, Aug. 23 (GenomeWeb News) - Protedyne said today that it has raised a total of $10 million in a Series D round of financing.


Investors included investment bank and new participant Allen & Company, as well as existing investors The Sprout Group, Meridian Venture Partners, Long River Ventures, Village Venture Partners, and Boston Community Venture Funds, Protedyne said.


Qiagen had also previously participated in the Round D financing, Protedyne said.


Protedyne plans to use the proceeds for working capital purposes, including enhancements to its BioCube laboratory automation product, the company said.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.